ClinicalTrials.gov record
Completed Phase 2 Interventional

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

ClinicalTrials.gov ID: NCT06384157

Public ClinicalTrials.gov record NCT06384157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 12:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Double Blind, Placebo Controlled, Randomised, Dose-Ranging Study to Assess the Safety and Efficacy of INDV-2000 Over 3 Months in Treatment Seeking Individuals With Opioid Use Disorder

Study identification

NCT ID
NCT06384157
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Indivior Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • INDV-2000 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 9, 2024
Primary completion
Sep 28, 2025
Completion
Nov 2, 2025
Last update posted
Dec 15, 2025

2024 – 2025

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
Boyett Health Services Inc Hamilton Alabama 35570
Elite Clinical Studies, LLC Phoenix Arizona 85018
North County Clinical Research Oceanside California 92054
Empire Clinical Research Pomona California 91767
Artemis Institute For Clinical Research - San Diego San Diego California 92103
Imagine Research of Palm Beach County Boynton Beach Florida 33435
Bold City Clinical Research Jacksonville Florida 32224
Vitalix Kissimmee Kissimmee Florida 34741
Accel Research Sites - Lakeland Lakeland Florida 33803
Quantum Clinical Trials Miami Beach Florida 33140
Segal Trials Miami Lakes Miami Lakes Florida 33016
Clinical Research Center of Florida Pompano Beach Florida 33060
Agile Clinical Research Trials Atlanta Georgia 30328
Maryland Treatment Centers Baltimore Maryland 21229
Vitalix Clinical Worcester Massachusetts 01608
Insight Research Institute Flint Michigan 48507
Precise Research Centers Flowood Mississippi 39232
Arch Clinical Trials St Louis Missouri 63141
IMA Clinical Research Las Vegas Nevada 89102
Oasis Clinical Research Las Vegas Nevada 89121
Richmond Behavioral Associates Staten Island New York 10314
Dr Vando Medical Services The Bronx New York 10464
Monroe Biomedical Research Monroe North Carolina 28112
West Clinical Research Morehead City North Carolina 28557
Midwest Clinical Research Center, LLC Dayton Ohio 45417
Pahl Pharmaceutical Professionals, LLC Oklahoma City Oklahoma 73112
SP Research PLLC Rivus Wellness and Research Insitute Oklahoma City Oklahoma 73112
Unity Clinical Research Oklahoma City Oklahoma 73118
Prisma Health Addiction Medicine Center Greenville South Carolina 29605
Insite Clinical Research, LLC DeSoto Texas 75115
El Paso Clinical Trials El Paso Texas 79902
HD Research Houston Texas 77043
Progressive Clinical Research Llc Bountiful Utah 84010
Alpine Research Organisation Clinton Utah 84015
Boeson Clinical Research Provo Utah 84604

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06384157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06384157 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →